Ocular side effects of anti-rheumatic medications: what a rheumatologist should know

被引：34
|
作者：
Peponis, V. [3 ]
Kyttaris, V. C. [1 ,2 ]
Chalkiadakis, S. E. [3 ]
Bonovas, S. [4 ]
Sitaras, N. M. [4 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Athens Eye Hosp, Eye Clin 2, Athens, Greece
[4] Univ Athens, Dept Pharmacol, Sch Med, GR-10679 Athens, Greece
来源：
LUPUS | 2010年 / 19卷 / 06期
关键词：
drugs; eye; hydroxychloroquine; lupus; INTERFERON-ASSOCIATED RETINOPATHY; ANTI-CD20; MONOCLONAL-ANTIBODY; TOXIC EPIDERMAL NECROLYSIS; OPEN-ANGLE GLAUCOMA; DOUBLE-BLIND; HYDROXYCHLOROQUINE RETINOPATHY; SULFASALAZINE TREATMENT; COMPARING CYCLOSPORINE; RETINAL COMPLICATIONS; INADEQUATE RESPONSE;
D O I：
10.1177/0961203309360539
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nearly every drug may cause changes to ocular tissues through a variety of mechanisms. Medication overdoses, drug-drug interactions but also chronic administration of medications at the recommended doses may lead to ocular toxicity. The ocular side effects, screening for eye toxicity and treatment guidelines for anti-inflammatory and immunosuppressive drugs commonly used by rheumatologists are reviewed herein. Lupus (2010) 19, 675-682.
引用
收藏
页码：675 / 682
页数：8
相关论文
共 17 条
  • [1] Paternal safety of anti-rheumatic medications
    Bermas, Bonnie L.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2020, 64 : 77 - 84
  • [2] Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?
    Andreoli, Laura
    Regola, Francesca
    Caproli, Alessia
    Crisafulli, Francesca
    Fredi, Micaela
    Lazzaroni, Maria-Grazia
    Nalli, Cecilia
    Piantoni, Silvia
    Zatti, Sonia
    Franceschini, Franco
    Tincani, Angela
    RHEUMATOLOGY, 2024, 63 (SI) : SI86 - SI95
  • [3] Ocular sarcoidosis: What the internist should know?
    Seve, P.
    Kodjikian, L.
    Jamilloux, Y.
    REVUE DE MEDECINE INTERNE, 2018, 39 (09): : 728 - 737
  • [4] Ocular Side Effects of Common Systemic Medications and Systemic Side Effects of Ocular Medications
    Syed, Misha F.
    Rehmani, Ahmad
    Yang, Matthew
    MEDICAL CLINICS OF NORTH AMERICA, 2021, 105 (03) : 425 - 444
  • [5] Current Weight Loss Medications: What Plastic Surgeons Should Know
    Wirth, Peter J.
    Shaffrey, Ellen C.
    Bay, Caroline
    Rao, Venkat K.
    AESTHETIC SURGERY JOURNAL, 2024, 44 (02) : NP177 - NP183
  • [6] Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis
    Min, Hong Ki
    Kim, Se Hee
    Kim, Hae-Rim
    Lee, Sang-Heon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [7] Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects
    Vishwakarma, Santosh
    Iyer, Lakshmi R.
    Muley, Milind
    Singh, Pankaj Kumar
    Shastry, Arun
    Saxena, Ambrish
    Kulathingal, Jayanarayan
    Vijaykanth, G.
    Raghul, J.
    Rajesh, Navin
    Rathinasamy, Suresh
    Kachhadia, Virendra
    Kilambi, Narasimhan
    Rajgopal, Sridharan
    Balasubramanian, Gopalan
    Narayanan, Shridhar
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 16 (01) : 72 - 78
  • [8] Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review
    Combe, Bernard
    Durez, Patrick
    Boone, Caroline
    Lula, Sadiq
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 658 - 667
  • [9] Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other
    Vitiello, Livio
    De Bernardo, Maddalena
    Nuzio, Salvatore Guercio
    Mandato, Claudia
    Rosa, Nicola
    Vajro, Pietro
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (01) : 1 - 8
  • [10] Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs
    Arias de la Rosa, Ivan
    Escudero-Contreras, Alejandro
    Ruiz-Ponce, Miriam
    Roman-Rodriguez, Cristobal
    Perez-Sanchez, Carlos
    Abalos-Aguilera, Maria del Carmen
    Ortega-Castro, Rafaela
    Alcaide, Juan
    Murri, Mora
    Font, Pilar
    Calvo-Gutierrez, Jerusalem
    Luque-Tevar, Maria
    Patino-Trives, Alejandra Maria
    Guzman-Ruiz, Rocio
    Malagon, Maria del Mar
    Tinahones, Francisco Jose
    Collantes-Estevez, Eduardo
    Lopez-Pedrera, Chary
    Barbarroja, Nuria
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12